Vol.

No.

June 14, 2024Jun 14, 2024

DOWNLOAD THE PDF

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

Cover Story

NCI

NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines

By Matthew Bin Han Ong

After a year of lean appropriations, NCI is looking at what threatens to be a budgetary cataclysm—a potential 10-11% cut to the Labor-HHS spending bill in fiscal year 2025.

Free Obituary

“Father of tamoxifen” V. Craig Jordan dies at 76

By MD Anderson Cancer Center staff

Clinical Trials & Tribulations

The thorny road to drug approval for myelodysplastic syndromes

By Mikkael A. Sekeres

Free Guest Editorial

Cancer centers, health providers should clearly signal that they welcome LGBTQI+ patients

By NFN Scout

Free In the Archives

In an interview and a memoir, V. Craig Jordan spoke about his life and SERMs

Editorial Free

The Cancer Letter receives six journalism, design awards

By Katie Goldberg

In Brief

Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores

City of Hope, Charles R. Drew University of Medicine and Science launch new educational research and training program

Oana Danciu named Big Ten CRC steering committee chair

Roswell Park earns “exceptional” rating from NCI with best-ever core grant

Jeffrey Farma named Fox Chase chair of surgery

Fox Chase received a total of $20M from Marvin and Concetta Greenberg

MUSC Hollings opens phase I cancer clinical trials unit

NCI seeking director of Office of Cancer Centers

ACS CAN says Consumer Financial Protection Bureau proposed rule is important step in reducing devastating impact of medical debt

Clinical Roundup

Fewer than 20% of U.S. adults eligible for lung cancer screening comply with USPSTF guideline

Cost-of-care discussions rarely documented for patients with advanced cancer

AI tool helps to diagnose and predict severity of lung cancers

AI improves physicians’ ability to identify prostate cancer extent

AI-based blood test outperforms ultrasound in early liver cancer detection

CAR T-cell therapy delivered to the brain shows clinical activity in glioblastoma in phase I study

Hydroxychloroquine + lapatinib may reduce breast cancer metastases

T-cell aging not limited by organismal age, allowing healthy cells to proliferate in perpetuity

Multispecific antibody shows promise for B cell lymphoma

Innovative PET scanner could change the way lung cancer is evaluated and treatment is assessed

Liver surgery to remove cancer can now be a safe outpatient procedure

Cells in tumor microenvironment play critical role in effectiveness of rapalogs

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

MD Anderson, Sibylla Biotech collaborate to develop small-molecule protein degraders

Atlantic Health System, Mevion collaborate to bring proton therapy technology to Carol G. Simon Cancer Center

Drugs & Targets

FDA approves Breyanzi for relapsed or refractory mantle cell lymphoma

FDA grants accelerated approval to Augtyro for NTRK gene fusion-positive solid tumors

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 52 | Issue 33 - September 11, 2026